|
Past Weekly
Updates
|
- April 8, 2014
- March 31, 2014
- March 24, 2014
- March 18, 2014
- March 11, 2014
- March 3, 2014
- Feb 21st, 2014
- Feb 14, 2014
- Feb 7, 2014
- Jan 31, 2014
- Jan 21. 2014
- Jan 14, 2014
|
|
Meet New SoCalBio Members
|
BioVinc (Culver City)
BioVinc offers the new fluorescent molecular probes targeting bone, based on technology developed by Professor Charles E. McKenna at the University of Southern California ... Learn more
Biolase specialize in the development, manufacturing and marketing of lasers and related products to provide biological treatments that eliminate pain and are safer for patients .. Learn more
ADRx (Thousand Oaks)
ADRx, Inc. is a biopharmaceutical company created to develop first-in-class and best-in-class drugs for amyloid diseases. The company intends to discover and develop drug candidates independently and in partnertnership with pharmaceutical and biotechnology companies ...
Biotechnical Services Inc. (San Diego)
Provides scientific lab equipment sales and services, such as calibration and validation.... Learn more
Response Genetics (Los Angeles)
Response Genetics is a publicly traded biotech company focused on developing molecular diagnostic assays to help determine the patient's response to cancer therapies ... Learn More
Pharmacos Biopharmaceutical Services (Irvine)
Pharmacos services small to mid-size specialty biopharmaceutical and medical device companies by providing a complete suite of outsourcing and/or consulting services which support drug development, registration, commercialization, life cycle management and commercial operations ..
CRB USA (Carlsbad)
CRB is a global design, construction and consulting firm that services the bioscience and other advanced technology industries. The firm employs over 600 people in 10 offices serving clients throughout the world ... Learn More
|
Join SoCalBio
Join SoCalBio leaders to promote the biotech and device industries in Los Angeles, Orange County and neighboring communities for job creation and overall economic growth.
|  |
| Thanks to SoCalBio Media Partners
|
|
|
|
MedTech Innovations
|
Disruptive MedTech Innovations Are Increasingly Coming from the Outside
 MDDI reports that -- based on a new study by PwC, -- "the U.S.'s nearly $3 trillion healthcare industry is experiencing the same sort of dramatic shift seen in retail, banking, entertainment, and other industries as "new entrants," companies whose core business resides entirely outside of healthcare or are expanding into new roles, capture more of the market". The list of outside entrants includes Samsung, Qualcomm, Google, Verizon, and .... Read more
|
|
Trends
|
Is Biotech Caught in a Bubble, and is it Popping?
 Russ Britt writes in MarketWatch "It's almost impossible to find stability in the biotech sector, and that task is made more difficult without a viable roadmap. So the question remains, should investors go along for the ride, or get out at the next stop? Is the latest drop in the sector the sound of a bubble popping, or a little air being let out before the sector goes on another run?" ... Read more
|
|
Interview
|
 Attorney David Hankin runs the Alfred Mann Foundation for Scientific Research in the Santa Clarita Valley, known for its medical breakthroughs. The San Fernando Valley Business Journal interviews Mr. Hankin to investigate how the Alfred Mann Foundation keeps the medical device pipeline full .... Access Interview (requires subscription) |
| Cut Cost of Business |
Enjoy Secure Document Sharing Services and Discounts from ShareVault
Available only to SoCalBio or BIO members in Southern California
 In collaboration with BIO, SoCalBio offers member companies preferential pricing and complimentary extra biotech/medtech-specific features on ShareVault's cutting-edge Virtual Data Room (VDR) technology and Secure Document Sharing services. Learn more and sign up for a free trial.
|
| BIO Legislative Day |
SoCalBio Voices Industry Concerns to Policy Makers in Washington D.C. During the BIO Legislative Day
On April 9, SoCalBio joined BIO, 47 regional bioscience industry associations from around the country and over 150 bioscience industry executives to visit Congress and advocate on behalf of the bioscience industry. The SoCalBio team was composed of the following: - Ahmed Enany, SoCalBio
- Dwain Morris-Irvin, StemVax
- John Isacson, Perkins Coie
- Kelly Davies, Johnson & Johnson
- Mitchell Goldstein, Loma Linda University Medical Center
- Wesley Mizutani, Healthcare Partners
Guided by Roy Zwahlen from BIO, the SoCalBio team did a superb job in educating policy makers about the economic contribution of the bioscience industry throughout the US and in Southern California. Members of the team advocated for an enlightened public policy to
- Support innovation commercialization,
- Speed up medical product approval,
- Protect Medicare benefits for the most vulnerable populations, and
- Cautioning against rushing patent litigation reform to satisfy the interests of the technology crowd at the expense of the intellectual property-intensive bioscience community.
SoCaLBio thanks the following for allowing us to visit their offices on the Hill and giving Us a chance to express industry needs and concerns to them personally or to their staff:
- Senator Barbara Boxer (D-CA)
- Congresswoman Linda Sanchez (D-38th)
- Congressman Buck McKeon (R-25th)
- Congresswoman Maxine Waters (D-43rd)
- Congressman Mark Takano (D-41st)
- Congressman Tony Cardenas (D-29th)
- Congressman Adam Schiff (D-28th)
- Congresswoman Janice Hahn (D-44th)
- Congressman Brad Sherman (D-30th)
- Congresswoman Lois Capps (D-24th)
|
SoCalBio Team on the Hill
SoCalBio Team with Congresswoman Linda Sanchez (D-Cerritos)
SoCalBio Team with Congressman Mark Takano (D-Riverside)
SoCalBio Team with Congressman Brad Sherman (D- West San Fernando Valley)
SoCalBio Team with Congresswoman Lois Capps (D- Santa Barbara)
|
|
|
Register Now
| |
SoCalBio Executive Luncheon
April 17, 11 am to 2 pm
at Biolase Inc. (Irvine)
Brian Horne, Partner, Knobbe Martens will explore the likely effect of current patent litigation reform legislation on the prospects of biotech and Medtech companies.
Coming in May
 May 15, 8 am to 4 pm, at Calit2 Auditorium in Irvine: SoCalBio Workshop: Accessing Government Grant Funding (open to the public)
|
|
Recommended Event
| |
Celebrate Medical Innovation at LA BioMed
Thursday, April 24, 2014 from -- 12:30 PM to 5:30 PM
Free for SoCalBio Members
|
| Regenerative Medicine |
UC Irvine Spinoff -- California Stem Cell Inc. -- Acquired for $120 Million
 The New York-Based NeoStem announced on April 14 that it has entered into a definitive agreement to acquire California Stem Cell, Inc. an Irvine-based stem cell biotechnology company founded by Hans Keirstead of UCI (photo right). "As a result of this acquisition, NeoStem plans to initiate a pivotal Phase 3 trial of Melapuldencel-T, an autologous melanoma initiating (stem) cell immune based therapy intended to eliminate the tumor cells capable of causing disease recurrence," NeoStem said ....See more
|
| Breast Cancer |
Here's What's Behind Puma's Crash
 Todd Campbell argues in the Motley Fools that the recent sharp decline of the West Los Angeles-based Puma Biotechnology may be due to overreaction by investors weary of the rich valuation ($3 billion) of a one product company. He says Pumas "data appears strong and suggests neratinib would probably outperform Herceptin in phase 3, but investors appear to have wanted a bigger confidence boost than a statistical likelihood in order to justify such a rich valuation... Read more
|
|
Heart Valve Market
|
Edwards Wins Limit on U.S. Sales of Medtronic CoreValve
According to Bloomberg, "Edwards Lifesciences Corp. won a court order limiting U.S. sales of Medtronic Inc.'s CoreValve system, a device approved by the Food and Drug Administration in January that was found to infringe Edwards patents ... Edwards and Medtronic are fighting for control of the developing market, valued to reach $3 billion a year, for heart valves that can be inserted without open-heart surgery. Medtronic's CoreValve and Edwards's Sapien XT are designed to help 300,000 people worldwide with aortic stenosis, a narrowing of the valve between the left ventricle and the aorta" ... Read more
|
|
Hypertension
|
ROX Medical Completes Enrollment in its Hypertension Device Study
 According to a press release by the San Clemente-based Rox, the company "has completed enrollment for CONTROL-HTN trial, an international multi center, prospective, randomized, controlled, blinded endpoint trial of the ROX Coupler for the treatment of arterial hypertension.... ROX Medical's FLOW procedure is a minimally invasive, under one-hour, straight forward, catheter based procedure performed by interventional cardiologists, radiologists and vascular surgeons. It places the ROX Coupler between a central artery and vein in the upper leg creating a fixed volume arterial-venous anastomosis, which immediately reduces blood pressure, and vascular resistance while increasing arterial compliance .... Read press release
|
| IPO Postponement |
Lombard Medical Postpones its IPO
The Irvine-base Lombard Medical, a British maker of endovascular stent-grafts for repairing aortic aneurysms, has postponed its planned $80 million IPO, due to market conditions. It had planned to trade on the Nasdaq under ticker symbol EVAR, with Jefferies and Barclays serving as lead underwriters... ..Read more
|
| Jobs ... Jobs ... jobs |
Bench International (Los Angeles)
Inogen (Goleta)
Carolina Liquid Chemistries
(Winston Salem, NC and Brea, Calif.)
Applied Biocode (Santa Fe Springs)
ADRx (Thousand Oaks)
Bioness (Santa Clarita)
Presbia (Irvine)
C3 Jian (Los Angeles)
Second Sight Medical Products (Sylmar)
Response Genetics (Los Angeles)
Bruin Biometrics (Los Angeles)
Chromologic (Pasadena)
- Sr. Engineer - Medchanical
- Senior Hardware Engineer - Machine Vision Systems
- Sr. Scientist - Optics
- Sr. Scientist - Biomedical Engineering
- Principal Research Scientist - Biologics
Gilead (San Dimas)
Gilead (Oceanside)
Biolase (Irvine)
Xencor (Monrovia)
Aubrey Group (Irvine)
|
|
| About SoCalBio |
 SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| Join SoCalBio | |
|
|
|
